David P Steensma

Hans Geiger-German physicist and the Geiger counter.

Marc A Shampo, Robert A Kyle, David P Steensma, 2011, Mayo Clinic proceedings.

Contract research organizations in oncology clinical research: Challenges and opportunities

David P Steensma, H. Kantarjian, D. Steensma, 2016, Cancer.

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Donna Neuberg, Steven M Kornblau, Johannes Köster, 2016, Cancer cell.

Niche-based screening identifies small-molecule inhibitors of leukemia stem cells.

Fatima Al-Shahrour, Anne E Carpenter, Benito Munoz, 2013, Nature chemical biology.

Cancer research in the United States: A critical review of current status and proposal for alternative models

Razelle Kurzrock, David P Steensma, R. Kurzrock, 2018, Cancer.

The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice.

Donna Neuberg, Steven M Kornblau, Johannes Köster, 2016, Cancer cell.

Are myelodysplastic syndromes "cancer"? Unexpected adverse consequences of linguistic ambiguity.

David P Steensma, D. Steensma, 2006, Leukemia research.

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes.

David P Steensma, Ayalew Tefferi, D. Gilliland, 2005, Blood.

Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer.

David P Steensma, P. Novotny, J. Sloan, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Myelodysplastic Syndromes: Diagnosis and Treatment.

David P Steensma, D. Steensma, 2015, Mayo Clinic proceedings.